A Bioequivalence Study to Compare VIMOVO Manufactured at AstraZenca AB to VIMOVO Manufactured by Patheon Pharmaceuticals and Marketed Enteric-coated Naproxen Formulation

NCT01331993 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Bioequivalence

Interventions

DRUG: VIMOVO (AstraZeneca)
DRUG: VIMOVO (Patheon)
DRUG: Marketed enteric-coated naproxen formulation

Sponsor

AstraZeneca